159 related articles for article (PubMed ID: 35732820)
21. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
[TBL] [Abstract][Full Text] [Related]
22. External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients.
Peilleron N; Seigneurin A; Herault C; Verry C; Bolla M; Rambeaud JJ; Descotes JL; Long JA; Fiard G
World J Urol; 2021 May; 39(5):1489-1497. PubMed ID: 32583038
[TBL] [Abstract][Full Text] [Related]
23. Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms.
Lodeta B; Baric H; Hatz D; Jozipovic D; Augustin H
BMC Urol; 2023 Nov; 23(1):190. PubMed ID: 37980520
[TBL] [Abstract][Full Text] [Related]
24.
Ferraro DA; Muehlematter UJ; Garcia Schüler HI; Rupp NJ; Huellner M; Messerli M; Rüschoff JH; Ter Voert EEGW; Hermanns T; Burger IA
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):147-159. PubMed ID: 31522272
[TBL] [Abstract][Full Text] [Related]
25. Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.
de Barros HA; Remmers S; Luiting HB; van Leenders GJLH; Roobol MJ; Bekers EM; Amin A; Haynes AM; Delprado W; Stricker PD; van der Poel HG; van der Kwast TH; van Leeuwen PJ
Urology; 2022 Oct; 168():156-164. PubMed ID: 35803346
[TBL] [Abstract][Full Text] [Related]
26. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
[TBL] [Abstract][Full Text] [Related]
27. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
[TBL] [Abstract][Full Text] [Related]
28. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
Hansen J; Rink M; Bianchi M; Kluth LA; Tian Z; Ahyai SA; Shariat SF; Briganti A; Steuber T; Fisch M; Graefen M; Karakiewicz PI; Chun FK
Prostate; 2013 Jan; 73(2):211-8. PubMed ID: 22821742
[TBL] [Abstract][Full Text] [Related]
29. External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy.
Dell'Oglio P; Abdollah F; Suardi N; Gallina A; Cucchiara V; Vizziello D; Zaffuto E; Cantiello F; Damiano R; Shariat S; Montorsi F; Briganti A
J Endourol; 2014 Apr; 28(4):416-23. PubMed ID: 24188052
[TBL] [Abstract][Full Text] [Related]
30. Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer.
Pellegrino F; Mazzone E; Stabile A; Beauval JB; Marra G; Campi R; Afferi L; Zhuang J; Sorce G; Rosiello G; Barletta F; Scuderi S; Guo H; Gontero P; Minervini A; Ploussard G; Montorsi F; Briganti A; Gandaglia G
Urol Oncol; 2023 Sep; 41(9):387.e17-387.e25. PubMed ID: 37198026
[TBL] [Abstract][Full Text] [Related]
31. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
Preisser F; van den Bergh RCN; Gandaglia G; Ost P; Surcel CI; Sooriakumaran P; Montorsi F; Graefen M; van der Poel H; de la Taille A; Briganti A; Salomon L; Ploussard G; Tilki D;
J Urol; 2020 Feb; 203(2):338-343. PubMed ID: 31437119
[TBL] [Abstract][Full Text] [Related]
32. Primary lymph-node staging with
Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
[TBL] [Abstract][Full Text] [Related]
33. Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissection.
Li Z; Huang Y; Zhao D; Luo X; Wu Z; Zheng X; Xie Y; Liu Y; Wu J; Peng Y; Li Y; Zhou F
Front Oncol; 2023; 13():1186319. PubMed ID: 37223684
[TBL] [Abstract][Full Text] [Related]
34. PI-RADS version 2: Preoperative role in the detection of normal-sized pelvic lymph node metastasis in prostate cancer.
Park SY; Shin SJ; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ; Oh YT
Eur J Radiol; 2017 Jun; 91():22-28. PubMed ID: 28629566
[TBL] [Abstract][Full Text] [Related]
35. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
[TBL] [Abstract][Full Text] [Related]
36. Positive node burden rather than the number of removed nodes impacts survival in patients with node-positive prostate cancer.
Guo XX; Guo RQ; Hou HM; Wang X; Wang JY; Liu M
Int J Clin Oncol; 2020 Dec; 25(12):2115-2121. PubMed ID: 32748296
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric MRI-based radiomics model to predict pelvic lymph node invasion for patients with prostate cancer.
Zheng H; Miao Q; Liu Y; Mirak SA; Hosseiny M; Scalzo F; Raman SS; Sung K
Eur Radiol; 2022 Aug; 32(8):5688-5699. PubMed ID: 35238971
[TBL] [Abstract][Full Text] [Related]
38. Comparison between Zumsteg classification and Briganti nomogram for the risk of lymph-node invasion before radical prostatectomy.
Branger N; Pignot G; Lannes F; Koskas Y; Toledano H; Thomassin-Piana J; Giusiano S; Alessandrini M; Rossi D; Walz J; Bastide C
World J Urol; 2020 Jul; 38(7):1719-1727. PubMed ID: 31560121
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic sentinel lymph node dissection in prostate cancer patients: the additional value depends on preoperative data.
Rousseau C; Rousseau T; Mathieu C; Lacoste J; Potiron E; Aillet G; Nevoux P; Le Coguic G; Campion L; Kraeber-Bodéré F
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1849-56. PubMed ID: 27164901
[TBL] [Abstract][Full Text] [Related]
40. Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis.
Leong JY; Herrera-Caceres JO; Goldberg H; Tham E; Teplitsky S; Gomella LG; Trabulsi EJ; Lallas CD; Fleshner NE; Tilki D; Chandrasekar T
Urology; 2020 Mar; 137():102-107. PubMed ID: 31705947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
